Haemonetics splits with Zimmer
This article was originally published in The Gray Sheet
Haemonetics Corp. will end its five-year U.S. distribution agreement with Zimmer for the OrthoPAT blood management system, the company announces Aug. 30. Haemonetics, which already sells OrthoPAT directly in Europe and Asia, will expand its sales and services operations to accommodate the extended U.S. customer base once Zimmer's distribution rights end in February 2006. Zimmer will pursue internal and external development of new blood salvage technologies...
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.